Solabia Group Acquires Algatech
23/05/2019
Paris, France — Solabia Group announced in a press release that it has acquired Algatech Ltd., which specializes in the development, cultivation and commercialization of ingredients delivered from microalgae for supplement, food and cosmetic brands.
The move seeks to bring better quality ß-1,3-glucans-based products to market
08 Aug 2019 --- Microalgae-derived ingredients player Algatech has licensed the rights and intellectual property related to the production of β-1,3-glucan from Euglena Gracilis
TA Associates backed French pharmaceutical company Solabia Group has acquired Algatech for an undisclosed sum.
Israel-based Algatech, founded in 1998, cultivates microalgae ingredients that are used by food supplements, food and cosmetics brands globally. [...]
Algatech is proud to announce its acquisition by French pharmaceutical company Solabia Group. We look forward to working with Solabia to drive innovation in the micro and macroalgae industries.
Algatechnologies will launch its new micro-encapsulated natural astaxanthin powder formulated for vision and brain health at Vitafoods this week.